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Extracranial applications of diffusion-weighted
magnetic resonance imaging
Abstract Diffusion-weighted MRI
has become more and more popular in
the last couple of years. It is already an
accepted diagnostic tool for patients
with acute stroke, but is more difficult
to use for extracranial applications
due to technical challenges mostly
related to motion sensitivity and sus-
ceptibility variations (e.g., respiration
and air-tissue boundaries). However,
thanks to the newer technical devel-
opments, applications of body DW-
MRI are starting to emerge. In this
review, we aim to provide an overview
of the current status of the published
data on DW-MRI in extracranial
applications. A short introduction to
the physical background of this
promising technique is provided,
followed by the current status, sub-
divided into three main topics, the
functional evaluation, tissue charac-
terization and therapy monitoring.
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Introduction
The theory of measuring self-diffusion, which is the
Brownian motion of the water molecules in the tissues,
by means of magnetic resonance imaging (MRI) was
already introduced by Carr and Purcell in 1954 [1]. Their
ideas were based on an article by Hahn et al. in which the
influence of self-diffusion on the measured signal was
described [2]. Carr and Purcell adapted the Hahn-echo
imaging scheme in order to obtain diffusion-insensitive T2
measurements of tissues and subsequently to quantify the
amount of self-diffusion in tissues. With the introduction of
a pulsed gradient spin-echo scheme by Stejskal and Tanner
in the late 1960s, the applicability of diffusion-weighted
(DW) nuclear MR was largely increased [3]. Their applied
gradient scheme allowed easier and more robust measure-
ments and enabled better definition of the actual diffusion
time allowed for proton movement in the tissues. Almost
all of the currently used diffusion measurements are based
on the Stejskal-Tanner gradient scheme.
Unfortunately, diffusion-weighted imaging suffers from
a number of technical challenges. As the diffusion
weighting needs to be repeated a large number of times
to allow accurate assessment of the diffusion of water
molecules, ultrafast imaging sequences are invaluable.
However, these ultrafast sequences are usually single-shot,
meaning they have a long echo train length (ETL). A long
ETL makes the sequences highly dependent on the effects
of tissue homogeneity and air-tissue boundaries (especially
in gradient-echo-based sequences). These dependencies
introduce a number of artifacts in the resulting images.
Due to the low incidence of movement artifacts and the
very high brain homogeneity and high signal-to-noise ratio
(SNR), most early research on DW-MRI was performed in
the brain. The first important clinical application was
reported in 1990, when Moseley et al. found that diffusion
imaging in a cat brain allowed the detection of ischemic
brain areas in the first 30 min after onset [4].
At about the same time, Le Bihan et al. suggested that
the brain perfusion could be viewed as a pseudo-diffusion
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process and could be approximated using the intravoxel
incoherent motion technique [5]. Later on, it was shown
that the incoherent motion was not only caused by a
combination of intra- and extracellular water molecules and
blood perfusion, but also had contributions from tubular
flow and intercellular hindrances to proton mobility, such
as fibrosis [6].
Clinically, DW-MR imaging is now an established
method used routinely at many institutions for the diagno-
sis of acute stroke [7]. Over the last few years, DW-MRI
has become increasingly used in extracranial organs. DW-
MRI of abdominal organs, for instance, is much more
difficult to perform due to physiological motion artifacts
(bowel, cardiac and respiratory motions) and the hetero-
geneous composition of the organs [8]. However, thanks to
faster imaging techniques, DW-MRI has been increasingly
applied for the functional evaluation of different organs
such as the kidneys and the salivary glands, to characterize
lesions, to monitor different treatment options and to
predict the outcome of therapy. In this article we outline the
biological basis of DW-MRI observations as well as review
extracranial applications of DW-MRI in assessing organ
functionality and for tissue characterization as well as
consider the potential of this method to monitor tumor
treatment and predict patient outcomes.
Basics of DW-MRI
In order to make an MRI sequence sensitive to the diffusion
of water molecules, the sequence is expanded with a
diffusion-sensitizing gradient scheme. Currently, the most
commonly used DW-MRI sequence is a combination of a
Stejskal-Tanner diffusion-sensitizing gradient scheme,
followed by a very fast, single-shot gradient-echo data
collection sequence (echoplanar imaging, EPI).
The Stejskal-Tanner scheme is based on the use of two
equal-sized gradients, separated by a 180 degree radio-
frequency (RF) pulse (Fig. 1).
The different effect of these two gradients on station-
ary and moving water molecules is explained in the
following figure (Fig. 2). Stationary molecules (such as
cubes 1 and 2) start off in phase with each other after the
90° RF pulse. The first gradient induces a faster rotation
in the molecules that are more to the right of the image
and a slower one on the left side, as indicated in the
image. The 180° RF pulse then rotates the vectors
around the vertical axis. If the molecules have not moved
substantially between the first and second gradient, the
extra rotation induced by the second gradient will be
identical to the first one, and all stationary molecules will
be in phase at the end of the second gradient. If cube 3 is
on position x1 during the first gradient, but on position
x2 during the second gradient, the second extra rotation
will no longer be identical to the first, and the molecule
will be out of phase.
An out-of-phase situation will yield a lower signal than
an in-phase configuration; therefore, the greater the
movement, the lower the signal measured will be. Also,
the higher the gradient strength G applied, the stronger this
signal loss will be. The amount of diffusion-sensitizing
applied is usually indicated by the b-value, which is given
by (see also the image above for a definition of the symbols
used):
b ¼ γ2 G2 δ2  Δ δ
3
 
where γ is the gyromagnetic ratio, G the strength of the
gradient used, δ the duration of the gradient andΔ the time
between the two gradients.
This signal loss as a function of the b-value (or diffusion
weighting) usually shows an exponential behavior (Fig. 3).
Quantification of the DW-MRI images is performed by
calculating the apparent diffusion coefficient (ADC) from
the generic formula for this decreasing exponential
behavior:
Si ¼ S 0 eb

i ADC
Fig. 1 Stejskal-Tanner gradient
scheme for diffusion-sensitiza-
tion of the tissue signal
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with Si the signal intensity measured using a b-value bi
and S0 the signal intensity for b=0 s/mm
2.
A major advantage of calculating ADC values is that
these values are independent of the position of the imaged
tissue in the receiver coils. However, all moving molecules
induce a signal loss and therefore contribute to the ADC
value. This means that the diffusion in the extracellular-
extravascular space, cellular diffusion and intravascular
perfusion all contribute to the calculated ADC value. Thus,
DW-MRI provides information on perfusion and diffusion
simultaneously in any organ. It has been shown that the
choice of b-values plays an important role in which of these
contributions has the most influence [5, 9]. The effect of
the movement on the ADC value is inversely related to
the speed of movement of the water molecules. Using
low b-values (typically up to 200 or 300 s/mm2), the
fastest moving spins have the strongest effect. The
origin of these fast spins is still under debate, but can
most likely be attributed to perfusion effects and guided
movement of extravascular extracellular water molecules
[9]. In higher b-values, the fastest moving spins have
already lost their signal; therefore, the effect of the
slower movements such as the Brownian displacement
of extra- and intracellular molecules and transmembra-
neous transport can be assessed [10].
Whenever the micro-architecture of a tissue is changed,
either with respect to the blood vessel density, the addition
or removal of structural inhibitors or most importantly by
the different ratio of extracellular extravascular space over
the intracellular space, this can be detected using DW-MRI,
provided an optimal choice of b-values is selected. The
ADC is reported to be related to the cellular density of a
tumor, for instance, and reduced ADC has been observed in
most types of malignant tumors due to the consequent
decrease of the extracellular extravascular space [11].
The second very important part of a diffusion-weighted
acquisition is the underlying imaging sequence used. In
theory, any imaging sequence can be adapted with bipolar
gradients to allow the assessment of water molecule
diffusion. However, due to time constrictions, predomi-
nantly single-shot sequences are used nowadays. The
fastest and most often used technique, EPI, is a gradient-
echo-based technique and therefore has the inherent
problems with susceptibility, especially when many air-
tissue boundaries are present. Also, movement artifacts
tend to have a stronger effect in gradient-echo acquisitions.
As both factors are more pronounced in extracranial
Fig. 2 Non-uniform effect in-
duced in stationary and moving
spins by the diffusion-sensitiz-
ing gradients
Fig. 3 Example of the relative signal intensity decrease with
increasing b-value on a (a) linear and (b) logarithmic scale. The
curve in the graphs represents a tissue with an apparent diffusion
coefficient of 0.001 mm2/s
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applications, some researchers tend to use alternative
acquisition schemes such as single-shot turbo-spin-echo,
steady-state free precession, multi-shot EPI and line scan
diffusion-weighted imaging. A comprehensive comparison
of these techniques is beyond the scope of the current
manuscript, but more information can be found in the
literature [12, and references therein].
Functional evaluation
As mentioned above, the mechanism of DW-MRI is based
on the movement of water molecules in tissue and more
importantly on the hindrances/facilitations of these water
molecule movements. From this idea, DW-MRI would
seem an ideal tool to examine the function of tissues that
are based on production, displacement or excretion of fluid.
The first uses of DW-MRI for the functional evaluation of
tissues were in the kidneys, as these have a high amount of
tubular perfusion and diffusion to allow for water and
waste product excretion. More recently, functional evalua-
tion by DW-MRI has spread to other organs that specialize
in fluid production and transport such as the salivary glands
and pancreas. Below, we consider how DW-MRI has been
used for the functional evaluation of each of these organs.
Several reports dealing with diffusion-weighted MRI of
the kidneys have been published. However, most of these
have been preliminary and performed in healthy volunteers
investigating the feasibility of DW-MRI and addressing
technical aspects [13–16]. For example, in healthy
children, an age-dependence of the ADC could be observed
with the greatest changes during the first years of life [17].
There has been an ongoing controversy about whether
ADC values are higher in the renal cortex or medulla.
While several papers found higher ADC values in the
medulla than in the cortex [14, 18, 19], more recent papers
including our own work found just the opposite [13, 20–
22]. Very different ADC values have been reported for
control kidneys ranging from 1.63×10−3 mm2/s [8] to
5.76×10−3 mm2/s [23]. These differences are primarily due
to the selected b-value ranges and hamper comparisons
between studies.
In experimental settings, DW-MRI has been applied in
the evaluation of renal artery stenosis (RAS) and ureteral
obstruction in pigs [24], showing a decrease of the ADC in
both pathologies, with diuresis having no meaningful
effect. In another study on pigs, DW-MRI was able to
differentiate acute and chronic ureteral obstruction [25].
Diabetic rats with cellular edema showed significantly
lower ADC values in the kidneys than the control group;
the results correlated with histopathological findings [26].
A decrease in ADC in dog kidneys following ischemia
induced by renal artery ligation has been described [27].
In patients with acute and chronic renal failure, ADC
values in the cortex and medulla were significantly lower
than those of the normal kidneys with ADC values being
lowest for patients with chronic renal failure [19, 22]. Also,
in patients with RAS the ADC values in the cortex, but not
in the medulla, were significantly lower than those of
normal and contralateral kidneys. Furthermore, a linear
correlation between renal ADC values and serum creati-
nine levels was observed [28]. DW-MRI may be applied
for the differentiation of pyonephrosis from hydronephro-
sis [29]. Another study [30] showed that ADC values in
hydronephrosis were reduced only if it was accompanied
by renal dysfunction. A positive correlation was observed
between ADC values and the split glomerular filtration rate
(GFR). In renal tumors different ADC values were
observed when compared to the normal renal parenchyma
[31].
In transplanted kidneys, DW-MRI has only been
performed in an animal study. In this experimental
transplant rejection model, ADC values in the cortex and
medulla decreased significantly, suggesting the potential of
this method for monitoring early graft rejection [21].
There are few reports on the use of DW-MRI for assess-
ing salivary gland function and tissue characterization
[32–35].
Decreased salivary function is an important component
of various pathological conditions and is itself associated
with many additional disorders. For example, salivary
gland dysfunction has an important clinical impact in
patients undergoing radiotherapy for head and neck cancer.
It was demonstrated that decreased salivary gland ADC
values correlated significantly with decreased salivary
function determined scintigraphically in patients after
radiotherapy [34]. However, the correlation between DW-
MRI and scintigraphic values was small. This may be due
to the fact that DW-MRI was performed at rest, whereas
scintigraphy was performed during gustatory stimulation
[34]. Employing DW-MRI in unstimulated salivary glands
does not reflect maximal saliva production. Therefore, in
two other studies DW-MRI was performed during gusta-
tory stimulation and was able to detect changes in ADC of
the salivary glands during stimulation [35, 36].
In patients with Sjögren’s syndrome, the ADC correlated
with the salivary flow rates. The ADC was increased in
patients with sialadenitis and decreased with abscess
formation [32].
Considerable discrepancies among ADC values of the
salivary glands in healthy volunteers are found in published
reports [32–34]. It has been shown that by varying the
contribution of molecular diffusion, tissue perfusion and
saliva flow, the ADC values are influenced by the chosen
b-values [9]. Therefore, attention has to be paid when
interpreting different studies.
In a recent study investigating parotid gland tumors of
45 patients, DW-MRI was reported to be able to differen-
tiate benign from malignant primary tumors by means of
the measured ADC values [37]. However, a differentiation
among the various histological types was not possible.
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In a recent study, DW-MRI of the pancreas was applied
before and after secretin administration in patients with
chronic pancreatitis in a risk group for chronic pancreatitis
and in healthy volunteers. The control subjects showed a
median peak increase in ADC of 75% after a median time
of 2 min after secretin administration, whereas in the
patients with chronic pancreatitis no ADC peak was
observed within 10 min after secretin administration.
These findings provide clinically relevant information for
detecting functional alterations in patients with chronic
pancreatitis [38].
Tissue characterization
One of the main problems in daily clinical practice is the
differentiation between benign and malignant lesions in
various organs that DW-MRI can address. The advantages
of DW-MRI in this aspect are entire tumor coverage and
safety in the assessment performed. In contradistinction,
tissue sampling is invasive and may not be representative
of the entire tumor and also carries the inherent risks of
infection, hemorrhage and seeding along the needle tract
[39]. It has been repeatedly noted that ADC is related to the
cellular density of tumors [11, 40–42]. Reduced ADC
values have been reported for most malignant tumors [16,
43, 44] and are thought to be due to cellular membranes
impeding the mobility of water protons [11, 41]. Necrotic
tissues, on the other hand, show high ADC values resulting
from larger diffusion distances as a consequence of lost
membrane integrity [11]. It is because of the high
sensitivity of DW-MRI to molecular displacements (in
the orders of microns; three orders of magnitude less than
the spatial resolution of a typical clinical MRI scan) that
this method is very sensitive to biophysical changes related
to pathologies, even during their very early stages of
development [45].
ADCmeasurements for the evaluation of hepatic fibrosis
showed decreased values as the stage of liver disease
progressed or as the Child-Pugh stage progressed [46].
This is an important finding that might help to reduce the
number of liver biopsies to assess the stage of disease in
patients with hepatic fibrosis. For example, in a prospective
study in 66 patients, DW-MRI was able to differentiate
between benign and malignant focal hepatic lesions, with
ADC of benign lesions being significantly higher than the
ADC of malignant lesions [47]. Metastatic lesions and
hepatocellular carcinomas had the lowest ADC, probably
due to their high cellularity, restricting water diffusion. All
malignant lesions included in this study were solid and did
not have cystic components that might have increased the
ADC. An interesting study published recently showed in a
small number of patients (n=6) that detection of malignant
lesions of the liver using DW-MRI was improved after
contrast enhancement with superparamagnetic iron oxide
thanks to the improved contrast-to-noise ratio between
malignant lesions and normal liver compared to conven-
tional MRI and DW-MRI alone [48].
In line with these findings is the reduced ADC of
malignant breast tumors compared to that of benign lesions
and normal tissue noted in 23 patients. This difference was
related to the increased cellularity of malignant lesions
[49]. Guo et al. also showed a statistical difference of ADC
value between malignant and benign breast lesions; the
sensitivity was 93% and specificity was 88% with an ADC
threshold of 1.30×10−3 mm2/s [50]. Similar results were
observed in a study performed on 76 patients with breast
carcinoma with a 95% sensitivity for malignant tumors
using a threshold of less than 1.6×10−3 mm2/s [51].
In contrast to this study, metastatic cervical lymph nodes
in patients with head and neck cancer had a significantly
higher ADC than those with benign nodes. An explanation
for this discrepancy might be that squamous cell
carcinomas tend to be partially necrotic and therefore to
have a higher ADC. In nodal lymphomas, however, the
ADC was significantly lower than in benign nodes in the
same study, apparently due to higher cellular density [52].
Furthermore, the ADC of metastatic nodes from highly or
moderately differentiated cancers was significantly greater
than that from poorly differentiated cancers. This is an
interesting issue; however, histo-pathological correlations
are required for further evaluation.
The accurate detection of recurrent or residual choleste-
atoma is challenging because differentiation from granu-
lation or fibrous tissue, which are common after surgery, is
often very difficult to discern by CT or conventional MRI.
Recently, several articles have shown the potential of DW-
MRI to depict recurrent or residual cholesteatoma in
patients who have undergone middle ear surgery [53–57].
It has been shown that vertebral metastases can also be
distinguished from normal vertebrae by their significantly
lower ADC values [58]. However, in daily practice the
differentiation between benign and malignant compression
fractures is a more important problem than the diagnosis of
vertebral metastases only. Therefore, the majority of the
articles published deal with this problem. In these articles,
it has been noted that metastatic compression fractures
have a lower ADC compared to benign, osteoporotic
compression fractures; therefore, the DW-MRI method
offers the potential for characterization of acute vertebral
compression fractures, which can be problematic in clinical
practice [58, 59]. Even qualitative analysis of DW-MRI has
been shown to be able to distinguish between benign and
malignant vertebral compression fractures [60, 61]. Benign
osteoporotic fractures were hypointense compared to the
surrounding normal bone marrow on DW-MRI, whereas in
malignant vertebral compression fractures, the signal
intensity was increased compared to that of normal bone
marrow [62]. These findings were confirmed in another
investigation [61]. In this study the ADC values were also
analyzed and were shown to be higher in benign compared
to malignant compression fractures. Qualitative analysis
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after radiotherapy of metastatic disease of the spine
evidenced a change from hyperintense signal before
therapy to hypointense relative to normal vertebral bodies
after therapy [63]. These findings suggest the potential of
DW-MRI to monitor the treatment response of successful
radiation therapy.
A study performed on 23 histologically proven soft
tissue tumors showed the ability of DW-MRI to differen-
tiate between benign and malignant lesions with true
diffusion coefficients of malignant tumors being signifi-
cantly lower than those of benign masses [64]. In contrast
to these findings, the ADC values of benign soft tissue
tumors overlapped with non-treated sarcomas, whereas the
ADC values increased in all radiated sarcomas, suggesting
the DW-MRI as a potential tool for evaluating treatment
response [65]. In contrast to the study of Rijswijk et al.
where true diffusion coefficients and perfusion fractions
were separated, in the study of Einarsdottir et al. only the
ADC values of two b-factors (0 and 600 s/mm2) were
calculated, a potential explanation for this discrepancy.
Overall, the use of DW-MRI in discriminating between
benign and malignant ovarian tumors has been disappoint-
ing due to prominent cystic components in this pathology
[66]. However, in another study performed on 131 patients
with cystic ovarian masses, the ADC was helpful in the
differential diagnosis of mature cystic teratomas with a
small amount of fat. The difference in ADC between
benign and malignant lesions was only significant when
mature cystic teratomas and endometrial cysts were
included, but was not significant when they were excluded
[67].
DW-MRI applied in addition to conventional T2W
imaging has been found to improve the detection of
prostate cancer [68]. In another study performed on a small
group of patients (n=10) with prostate cancer using an
endorectal coil, the mean ADC value of malignant tumors
in the peripheral zone was lower than that of non-malignant
glandular tissues with an overlap between individual values
[69]. In a recently published study performed on a 3-T MR
unit on 49 patients, the ADC values were lower for tumors
compared to the normal-appearing peripheral zone; how-
ever, a considerable intersubject variability was observed
[70].
Monitoring of treatment response
The prediction and detection of the therapeutic response as
well as characterization of residual disease are of utmost
importance in cancer imaging. DW-MRI has been used as a
way of assessing tumor response during follow-up with
various treatment modalities (e.g., chemotherapy and
radiation therapy) [71–75]. In these settings, DW-MRI
has a number of advantages over other imaging techniques
(e.g., CT and PET). DW-MRI is noninvasive, requires no
ionizing radiation exposure and does not require the
administration of contrast medium. The short examination
time, especially when using parallel imaging, is an
additional advantage, as is the ability to assess the tumor
completely. In addition, parallel imaging offers the bene-
fit of reduced artifacts, which becomes very important
in DW-MRI. The early detection of non-responders or
even prediction of response to treatment would allow
changes of therapy in order to minimize treatment-related
toxicity. Furthermore, both conventional morphologic and
physiologic assessments can be made during the same
examination.
Pre-therapy ADC maps can indicate the eventual
outcome of therapy. An initial and transient decrease in
ADC following therapy may be observed, probably repre-
senting pre-apoptotic cellular swelling. An increase in
ADC thereafter due to the onset of apoptosis and present
necrosis corresponds to successful therapy. The change in
ADC following treatment may predict the outcome of
therapy. A decrease in ADC later on, however, raises the
suspicion of tumor recurrence [73].
The ability to predict therapy outcome has been shown
by a preliminary study in 14 patients with locally advanced
rectal cancer, where a strong negative correlation was
found between mean pre-treatment tumor ADC and the
percentage size change of tumors after chemotherapy and
chemoradiation [71]. In an experimental setting, DW-MRI
has been used for monitoring the effect of a vascular
targeting agent, Combretastatin A-4 phosphate (CA4P), on
rhabdomyosarcomas in rats [73]. DW-MRI allowed
noninvasive detection and quantification of antivascular
effects and as well provided information on the differen-
tiation between the remaining viable and treated necrotic
tumor tissues. Furthermore, when DW-MRI was applied
for in vivo monitoring of repeated administrations of
CA4P, the pre-treatment ADC values correlated with the
outcome after CA4P administration; this study emphasized
the potential of DW-MRI as a predictive biomarker for
treatment outcome. In another experimental study again
looking at CA4P effects, a good correlation between
perfusion-associated ADC values and perfusion parameters
from dynamic contrast-enhanced MRI (DCE-MRI) were
found. While DCE-MRI was more sensitive to smaller
vascular changes, only the ADC of high b-values allowed
differentiation between viable and necrotic tumor tissue
[76].
Further evidence of the ability of DW-MRI to monitor
therapy effects comes from studies of ablated tissues after
focused ultrasound treatment of uterine fibroids. The ADC
values for treated fibroids were significantly higher than
the ADC values of untreated fibroid tissue in a prospective
study on 14 patients [77]. Similar results have been
obtained in a small group of patients (n=8) undergoing
transarterial chemoembolization of large hepatocellular
carcinomas, where DW-MRI was able to predict the degree
of tumor necrosis [78].
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Conclusion
DW-MRI has the potential to investigate both the biolog-
ical and the structural character of tissues. It has great
potential in the assessment of the functional status of
different organs, in the differentiation between benign and
malignant lesions, in the monitoring of various treatment
strategies and even in the prediction of outcome. However,
a strong collaboration among radiologists, physicists and
clinicians is the prerequisite for a successful extracranial
application of DW-MRI.
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